HalesCMServaisJMartinCBKohenD.Prescription drug use among adults aged 40–79 in the United States and Canada. NCHS Data Brief, no 347. Hyattsville, MD: National Center for Health Statistics. 2019. https://www.cdc.gov/nchs/products/databriefs/db347.htm#Data(Accessed July 27, 2022)
2.
Medication safety in polypharmacy. Geneva: World Health Organization; 2019. (WHO/UHC/SDS/2019.11). Licence: CC BY-NC-SA 3.0 IGO.
3.
Preventing medication errors. Institute of Medicine. Washington, DC: The National Academies Press, 2007. https://doi.org/10.17226/11623. (Accessed July 27, 2022)
LangfordBJSoMRaybardhanSLeungVSoucyJ-PRWestwoodD, et al. Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. 2021;27(4):520–31.
7.
Calderón-ParraJMuiño-MiguezABendala-EstradaAD, et al; Inappropriate antibiotic use in the COVID-19 era: Factors associated with inappropriate prescribing and secondary complications. Analysis of the registry SEMI-COVID. PLoS One. 2021 May 11;16(5): e0251340.
8.
PaudyalVSunSHussainRAbutalebMHHedimaEW. Complementary and alternative medicines use in COVID-19: A global perspective on practice, policy and research. Res Social Adm Pharm. 2022 Mar;18(3):2524–2528.
9.
Implications of the COVID-19 Pandemic for Patient Safety. A rapid review. Geneva: World Health Organization, 2022.
10.
DonaldsonLJKelleyETDhingra-KumarNKienyMPSheikhA. Medication Without Harm: WHO's Third Global Patient Safety Challenge. Lancet. 2017 Apr 29;389(10080):1680–1681.
11.
SheikhADhingra-KumarNKelleyEKienyMPDonaldsonLJ. The third global patient safety challenge: tackling medication-related harm. Bull World Health Organ. 2017 Aug 1;95(8):546–546A.